138 related articles for article (PubMed ID: 38216836)
1. BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway.
Chen X; Yang F; Zhang C; Wang X; Yuan C; Shi D; Zhu S; Zhang X; Chen X; Zhao W
J Mol Histol; 2024 Apr; 55(2):159-167. PubMed ID: 38216836
[TBL] [Abstract][Full Text] [Related]
2. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway.
Wan B; Cheng M; He T; Zhang L
BMC Cancer; 2024 May; 24(1):618. PubMed ID: 38773433
[TBL] [Abstract][Full Text] [Related]
3. USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth
Xu J; Gui GSW; Yang C; Zhu S; Chen Z; Ma SLB; Yang C; Bu CRL; Zhu Y; Xu W
Curr Mol Med; 2024; 24(5):667-675. PubMed ID: 37921189
[TBL] [Abstract][Full Text] [Related]
4. Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/β-Catenin Signaling Pathway.
Mao H; Xu Y; Zhang Z; Sun G; Wang Z; Qiao D; Yin X; Liu S; Bo P
Cancer Manag Res; 2020; 12():2697-2709. PubMed ID: 32425592
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway.
Song XZ; Xu XJ; Ren XN; Ruan XX; Wang YL; Yao TT
Onco Targets Ther; 2020; 13():8907-8917. PubMed ID: 32982283
[TBL] [Abstract][Full Text] [Related]
6. Short hairpin RNA silencing of TGF-βRII and FZD-7 synergistically suppresses proliferation and metastasis of hepatocellular carcinoma cells.
Chen C; Xue Y; Zhang D; Xu W; Xu H; Yao H; Pei D; Gu Y
Oncol Lett; 2016 Mar; 11(3):2039-2046. PubMed ID: 26998118
[TBL] [Abstract][Full Text] [Related]
7. CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling.
Lei S; Du X; Tan K; He X; Zhu Y; Zhao S; Yang Z; Dou G
Exp Ther Med; 2023 Jul; 26(1):314. PubMed ID: 37273753
[TBL] [Abstract][Full Text] [Related]
8. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
[TBL] [Abstract][Full Text] [Related]
9. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.
Fang L; Gao C; Bai RX; Wang HF; Du SY
Cancer Gene Ther; 2021 Aug; 28(7-8):875-891. PubMed ID: 32978504
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
Liu L; Huang Z; Chen J; Wang J; Wang S
J Exp Clin Cancer Res; 2018 Jul; 37(1):142. PubMed ID: 29986744
[TBL] [Abstract][Full Text] [Related]
13. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways.
Chen W; You J; Zheng Q; Zhu YY
Cancer Manag Res; 2018; 10():1817-1826. PubMed ID: 29997441
[TBL] [Abstract][Full Text] [Related]
15. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
[TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D.
Zhou Y; Liu X; Gao Y; Tan R; Wu Z; Zhong Q; Zeng F
Curr Pharm Biotechnol; 2021; 22(9):1246-1253. PubMed ID: 33038910
[TBL] [Abstract][Full Text] [Related]
17. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
18. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
Liu Y; Ma J; Lu S; He P; Dong W
Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
[TBL] [Abstract][Full Text] [Related]
19. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
